Biotech startup Immunai picks up $60m Series A: TechCrunch

Immunai, a biotech startup, has raised $60 million in Series A funding, according to TechCrunch.

Immunai, a biotech startup, has raised $60 million in Series A funding, according to TechCrunch. Immunai’s backers include Schusterman Family Investments, Duquesne Family Office, Catalio Capital Management, and Dexcel Pharma.

Source: TechCrunch